AI launches Grok Business & Enterprise AI plans with enterprise security, no data training, and higher limits.

Portfolio management, to some extent, seems more like an art to me than an exact science. Check out two of my biggest pieces ...

Novo Nordisk’s oral Wegovy gets FDA approval, but rising costs and competition threaten profits. Learn why analysts rate NVO ...

Q4 bear market, key $195 support, AI-driven growth outlook to FY2028, Nvidia/hyperscaler risks, and buy level—read now.

Alibaba remains a buy as accelerating AI-driven cloud growth and expanding AI applications show that the outlook is bright.

Make no mistake, either Agentforce is Salesforce's future or its future looks pretty bleak. For now, most CRM investors are ...

Global equities posted strong gains in 2025, driven by the US technology mega-caps. But the artificial intelligence trade ...

Calamos US Eq Autocallable Income ETF offers a unique structure to convert long-term equity returns into high-yield monthly ...

Read why the 4% retirement rule may be riskier than it seems, and how we recommend to invest in dividend stocks instead.

The key investor takeaway is that the AI sector still appears in the early innings of investment. The OpenAI funding story ...

Infosys stock is upgraded to "Buy" on potential Q3 beat and AI tailwinds. Here's what you need to know about the company.

Dividend growth investing for multigenerational wealth: why moderate-yield dividend stocks beat over time, and why 2026 ...